Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Cy3 TSA Fluorescence System Kit: Benchmarking Signal Ampl...

    2025-12-20

    Cy3 TSA Fluorescence System Kit: Benchmarking Signal Amplification in IHC & ISH

    Executive Summary: The Cy3 TSA Fluorescence System Kit (SKU: K1051) from APExBIO enables detection of low-abundance proteins and nucleic acids by tyramide signal amplification (TSA), using horseradish peroxidase (HRP)-catalyzed deposition of Cy3-tyramide for highly localized, covalent signal amplification [product]. The Cy3 fluorophore offers excitation at 550 nm and emission at 570 nm, suitable for standard fluorescence microscopy. The kit is validated for immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) applications [DOI]. Compared to conventional detection, TSA achieves at least 10-fold higher sensitivity under optimized conditions. The kit supports long-term storage (up to 2 years) under recommended temperatures and is for research use only.

    Biological Rationale

    Detection of low-abundance biomolecules in tissue and cellular samples is a central challenge in biomedical research. Conventional immunohistochemistry and in situ hybridization methods often fail to reveal proteins or nucleic acids present at sub-nanomolar concentrations due to limited signal-to-noise ratios. TSA technology, as implemented in the Cy3 TSA Fluorescence System Kit, addresses this by amplifying detection signals through the enzymatic deposition of labeled tyramide near the site of HRP activity [internal]. This approach is especially critical in studies of gene regulation, cancer biology, and epigenetics, where spatially resolved, ultrasensitive detection of targets such as long non-coding RNAs (lncRNAs) or post-translational protein modifications is required [DOI].

    Mechanism of Action of Cy3 TSA Fluorescence System Kit

    The kit employs an HRP-linked secondary antibody to catalyze the oxidation of Cy3-labeled tyramide. This generates a highly reactive intermediate that rapidly and covalently binds to tyrosine residues on nearby proteins or nucleic acids. The result is a dense, localized fluorescent signal at the site of the biomolecular target. The Cy3 fluorophore, with excitation at 550 nm and emission at 570 nm, ensures compatibility with most standard filter sets in fluorescence microscopy platforms [product]. Each kit contains dry Cyanine 3 Tyramide (to be dissolved in DMSO), Amplification Diluent, and Blocking Reagent. Proper storage at -20°C (Cyanine 3 Tyramide) or 4°C (diluent/reagent) ensures stability for up to 2 years. The covalent nature of deposition minimizes signal diffusion and enhances spatial precision [internal].

    Evidence & Benchmarks

    • Tyramide signal amplification increases detection sensitivity in IHC and ISH by 10–100 fold compared to direct or indirect immunofluorescence (van Gijlswijk et al., https://doi.org/10.1016/S0003-2697(97)00424-8).
    • The Cy3 TSA system enables detection of low-abundance lncRNAs in formalin-fixed paraffin-embedded tissue, as demonstrated in recent gastric cancer research (Zhu et al., https://doi.org/10.1080/15592294.2025.2512764).
    • HRP-catalyzed tyramide deposition produces subcellular spatial resolution of fluorescent signals, outperforming non-covalent labeling methods (Choi et al., https://doi.org/10.1038/nmeth.2637).
    • Signal stability and photostability are superior with covalent Cy3 labeling compared to non-covalent fluorophore conjugates (internal data, product page).

    This article extends the quantitative focus found in "Cy3 TSA Fluorescence System Kit: Enabling Quantitative Ep..." by providing detailed mechanistic and benchmark data for translational applications. It also clarifies the mechanistic context described in "Rewriting the Limits of Biomolecule Detection: Mechanisti..." by mapping kit performance to peer-reviewed benchmarks.

    Applications, Limits & Misconceptions

    The Cy3 TSA Fluorescence System Kit is validated for:

    • Immunohistochemistry (IHC) of formalin-fixed, paraffin-embedded (FFPE) or frozen tissue sections.
    • Immunocytochemistry (ICC) of fixed cultured cells.
    • In situ hybridization (ISH) for detection of RNA or DNA targets at high sensitivity.
    • Multiplexed detection protocols, provided spectral separation is maintained between fluorophores.

    Notably, the kit is not intended for live-cell imaging due to the requirement for fixed/permeabilized samples. It is also not suitable for diagnostic or medical use, per manufacturer guidelines [product].

    Common Pitfalls or Misconceptions

    • Tyramide amplification is not compatible with live-cell imaging; fixation is required to prevent diffusion and background.
    • Over-amplification can produce high background if blocking and washing steps are insufficient.
    • The Cy3 emission spectrum overlaps with some red fluorophores; multiplexing requires careful spectral separation.
    • The system is not quantitative for absolute copy number measurements, but excels at relative signal enhancement.
    • Use in diagnostic workflows is prohibited; for research use only.

    Workflow Integration & Parameters

    The kit workflow integrates into standard IHC, ICC, or ISH protocols following antigen retrieval and blocking. Typical protocol steps:

    • Incubation with primary antibody or probe (targeting protein or nucleic acid of interest).
    • Application of HRP-conjugated secondary antibody or detection reagent.
    • Incubation with Cy3-tyramide working solution (prepared fresh in amplification diluent).
    • Stringent washing steps to remove unbound tyramide and minimize background.
    • Mounting and imaging using filter sets appropriate for 550 nm excitation and 570 nm emission.

    Controls should include omission of primary antibody or probe to assess background. Storage of Cyanine 3 Tyramide at -20°C (protected from light) preserves reagent integrity for up to 2 years; diluent and blocking reagents are stable at 4°C for similar duration [product].

    Conclusion & Outlook

    The Cy3 TSA Fluorescence System Kit from APExBIO represents a benchmark for ultrasensitive, spatially precise detection of proteins and nucleic acids in fixed samples. Its HRP-catalyzed tyramide deposition platform enables researchers to detect targets previously below the threshold of conventional fluorescence methods. As demonstrated in recent studies of lncRNA roles in cancer, this type of amplification is essential for dissecting epigenetic regulation in complex tissue environments [DOI]. Ongoing improvements in protocol optimization and multiplexing strategies will further expand the utility of this tyramide signal amplification kit in translational research and biomarker discovery.